Inventor · disambiguated record
Vijayalaksmi Arumugam
Also filed as: ARUMUGAM VIJAYALAKSMI
40 granted patents·14 pending applications·681 citations·filing 2006–2024
98Inventor score
Files withVERTEX PHARMA45HADIDA-RUAH SARA SABINA6HADIDA-RUAH SARAH1MARTINBOROUGH ESTHER1MARTINBOROUGH ESTHER ANN1
Top patents by PatentIndex Score
54 records- 0198US10087143B2Pyridone amides as modulators of sodium channelsVERTEX PHARMA·Filed 2017·Granted Oct 2, 2018·19 cites·51 claims
- 0298US9758483B2Pyridone amides as modulators of sodium channelsVERTEX PHARMA·Filed 2016·Granted Sep 12, 2017·20 cites·35 claims
- 0398US9393235B2Pyridone amides as modulators of sodium channelsVERTEX PHARMA·Filed 2015·Granted Jul 19, 2016·24 cites·26 claims
- 0498US9351962B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2015·Granted May 31, 2016·49 cites·19 claims
- 0598US9051270B2Pyridone amides as modulators of sodium channelsVERTEX PHARMA·Filed 2014·Granted Jun 9, 2015·36 cites·29 claims
- 0697US10758534B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2019·Granted Sep 1, 2020·13 cites·38 claims
- 0797US10738009B2Pyridone amides as modulators of sodium channelsVERTEX PHARMA·Filed 2018·Granted Aug 11, 2020·10 cites·15 claims
- 0897US10258624B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·32 cites·47 claims
- 0997US9782408B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2015·Granted Oct 10, 2017·33 cites·84 claims
- 1097US9783501B2Substituted quinolines as modulators of sodium channelsVERTEX PHARMA·Filed 2015·Granted Oct 10, 2017·31 cites·23 claims
- 1197US8962856B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Feb 24, 2015·61 cites·37 claims
- 1297US7999113B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2006·Granted Aug 16, 2011·121 cites·25 claims
- 1396US11426407B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Granted Aug 30, 2022·6 cites·47 claims
- 1496US9421196B2Amides as modulators of sodium channelsVERTEX PHARMA·Filed 2015·Granted Aug 23, 2016·23 cites·18 claims
- 1595US12421251B2Cystic fibrosis transmembrane conductance regulator modulating agentsVERTEX PHARMA·Filed 2020·Granted Sep 23, 2025·5 cites·25 claims
- 1695US10647661B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2018·Granted May 12, 2020·15 cites·106 claims
- 1795US9108903B2Amides as modulators of sodium channelsVERTEX PHARMA·Filed 2014·Granted Aug 18, 2015·33 cites·20 claims
- 1894US9139529B2Substituted quinoxalines as sodium channel modulatorsVERTEX PHARMA·Filed 2014·Granted Sep 22, 2015·26 cites·35 claims
- 1994US8586615B2Modulators of cystic fibrosis transmembrane conductance regulatorHADIDA-RUAH SARAH·Filed 2011·Granted Nov 19, 2013·72 cites·21 claims
- 2093US12168009B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2022·Granted Dec 17, 2024·1 cites·46 claims
- 2193US11673864B2Pyridone amides as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Jun 13, 2023·2 cites·17 claims
- 2293US11603351B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Mar 14, 2023·3 cites·27 claims
- 2392US9511067B2Substituted spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]s as modulators of ion channelsVERTEX PHARMA·Filed 2014·Granted Dec 6, 2016·17 cites·30 claims
- 2491US12281057B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Apr 22, 2025·1 cites·15 claims
- 2591US11203571B2Sulfonamides as modulators of sodium channelsVERTEX PHARMA·Filed 2014·Granted Dec 21, 2021·8 cites·26 claims
- 2688US2025205232A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 2786US7799822B2Phenyl sulfonamides as modulators of ion channelsVERTEX PHARMA·Filed 2006·Granted Sep 21, 2010·8 cites·15 claims
- 2881US8598164B2Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channelsHADIDA-RUAH SARA SABINA·Filed 2011·Granted Dec 3, 2013·5 cites·68 claims
- 2978US8916565B2Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channelsHADIDA RUAH SARA SABINA·Filed 2012·Granted Dec 23, 2014·3 cites·35 claims
- 3075US8163720B2Pyrrolidinyl phenyl sulphonamides as modulators of ion channelsMARTINBOROUGH ESTHER·Filed 2010·Granted Apr 24, 2012·2 cites·16 claims
- 3170US8309587B2Piperidine and piperazine phenyl sulphonamides as modulators of ion channelsMARTINBOROUGH ESTHER ANN·Filed 2012·Granted Nov 13, 2012·2 cites·28 claims
- 3261US9856248B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2016·Granted Jan 2, 2018·0 cites·1 claims
- 3359US12503439B2Heteroaryl compounds for the treatment of painVERTEX PHARMA·Filed 2023·Granted Dec 23, 2025·0 cites·35 claims
- 3458US8586589B2Piperidine and piperazine phenyl sulfonamides as modulators of ion channelsVERTEX PHARMA·Filed 2012·Granted Nov 19, 2013·0 cites·29 claims
- 3558US2025388543A1Heteroaryl compounds for the treatment of painVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 3656US2023382924A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3756US2023416275A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3856US2023373974A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3956US2023382925A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4056US2023373939A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4156US2023373935A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4256US2023365587A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4356US2024018161A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4456US2023374038A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4556US2024150377A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4655US9181273B2Morpholine-spirocyclic piperidine amides as modulators of ion channelsVERTEX PHARMA·Filed 2014·Granted Nov 10, 2015·0 cites·21 claims
- 4752US2017145011A1Pyrrolopyrazine-Spirocyclic piperidine amides as modulators of ion channelsVERTEX PHARMA·Filed 2016·Application pending·0 cites
- 4851US12440481B2Esters and carbamates as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Oct 14, 2025·0 cites·23 claims
- 4951US2014171427A1Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channelsHADIDA-RUAH SARA SABINA·Filed 2013·Application pending·0 cites
- 5050US12441703B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Oct 14, 2025·0 cites·23 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Vijayalaksmi Arumugam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →